Pharmacology of fluticasone propionate

Journal of Investigational Allergology and Clinical Immunology

Volumn 7, Issue 5, 1997, Pages 382-384

  Sastre, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE;

ASTHMA; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BINDING; DRUG METABOLISM; GASTROINTESTINAL ABSORPTION; LIVER METABOLISM;

ADMINISTRATION, INHALATION; ANDROSTADIENES; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL AVAILABILITY; HUMANS; LUNG;

EID: 0030690572     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. - Fuller, R., Johnson, M., Bye, A. Fluticasone propionate - An update on preclinical and clinical experience. Respir Med 1994, 88 (Suppl. A): 3-18.
2. - Harding, S.M. The human pharmacology of fluticasone propionate. Respir Med 1990, 84 (Suppl A): 25-9.
3. - Högger, P., Rohdewald, P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroid 1994, 59: 597-602.
4. - Holliday, S., Faulds, D., Sorkin, E. Inhaled fluticasone dipropionate. A review of its pharmacodinamic properties, and therapeutic use in asthma. Drugs 1994, 47: 318-31.
5. - Pedersen, S., O'Byme, P. A comparison of the efficacy and safety of inhaled corticosteroid in asthma. Allergy 1997, 52 (Suppl. 39): 1-34.
6. - Shaw, R.J. Pharmacology of fluticasone propionate. Respir Med 1994, 88 (Suppl. A): 5-8.